Brickell Biotech launches brand reset amid positioning pivot 

BOULDER —  Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as the company seeks to pivot away from drugs that combat excessive sweating toward treatments for autoimmune, inflammatory and other debilitating diseases.

The company is now calling itself Fresh Tracks Therapeutics Inc. and expects to trade under the new Nasdaq ticker symbol FRTX beginning Thursday. 

As of Wednesday afternoon, Fresh Tracks Therapeutics had not been registered as a trade name with the Colorado Secretary of State’s office.

The rebrand comes less than a half-year after…